📰 Alembic News
Page 4 - Alembic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alembic. Real-time updates on events, politics, business and more.
February 27, 2021
Skip to main content Currently Reading An S.F. bar parklet was vandalized with message about homelessness. The bars owners had a surprising reply FacebookTwitterEmail A parklet belonging to Haight-Ashbury bar The Alembic was vandalized with graffiti Thursday. Vandals also installed curtains, a welcome mat and a makeshift dining table.Alembic A parklet belonging to Haight-Ashbury bar The Alembic was vandalized with graffiti Thursday in what the bar’s owner characterized as an unsolicited piece...
February 22, 2021
The sector that had peaked out on the bourses in 2015 saw buying interest due to the focus on healthcare. However, the interest is likely to wane as Covid recedes.
February 11, 2021
Indian pharma grows for 5th straight month; sales rise 4.5% in January Growth in the Indian pharma market is expected to be linear ahead. The market has now grown for the fifth consecutive month and the momentum is likely to improve Niti Kiran | February 14, 2021 | Updated 12:54 IST The Indian pharmaceutical markets (IPM) maintained its growth trajectory for the fifth consecutive month by expanding 4.5 per cent in January. After growing 8.5 per cent in December, it grew 4.5 per cent last mont...
February 10, 2021
Explore Now Mumbai: NSE will add 6 stocks to the F&O segment from March series, the exchange said in a notification on Tuesday. These include Alembic Pharmaceuticals, City Union Bank, Granules India, Gujarat Gas, L&T Technology Services and Mphasis. The futures and options contracts on these six securities would be available for trading with effect from February 26, the exchange said. Read this article in :Hindi Read More News on
February 9, 2021
Read more about Nifty hover above 15,200 mark; breadth positive on Business Standard. Benchmark indices hover near days high in afternoon trade. At 13:20 IST, the barometer index, the S&P BSE Sensex, jumped 365.71 points or 0.71% at 51,714.48. The Nifty 50 index spurted 116.30 points or 0.77% at 15,232.10.
February 9, 2021
Updated: Share Article AAA Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its novel, next generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood cancer. The drug, which has been licensed to TG Therapeutics since 2012, has bagged the approval for the U.S. market. TG Therapeutics h...
February 8, 2021
With five observations Alembic Pharmaceuticals announced that United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals New Injectable Facility (F-3) located at Karkhadi from 29 January 2021 to 5 February 2021. This was a scheduled inspection and at the end of the inspection, the USFDA issued a Form 483 with 5 observations. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a...
January 29, 2021
Read more about Alembic consolidated net profit rises 25.81% in the December 2020 quarter on Business Standard. Sales rise 13.48% to Rs 14.48 crore
January 19, 2021
YES Banks board will meet on Friday to consider a proposal for further fundraising through various means.
December 29, 2020
Investors with a short term perspective can buy the stock of Alembic at current levels. The stock had encountered key resistance at around ₹120 in mid-September 2020 and was on a medium-term downtrend